IRIS
GABRIELLI, Armando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.035
EU - Europa 5.653
AS - Asia 1.119
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 7
AF - Africa 4
SA - Sud America 2
Totale 16.834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.010
UA - Ucraina 1.350
IT - Italia 986
SE - Svezia 889
IE - Irlanda 749
DE - Germania 613
DK - Danimarca 464
TR - Turchia 459
FI - Finlandia 254
SG - Singapore 243
KR - Corea 237
GB - Regno Unito 186
CN - Cina 96
FR - Francia 69
IN - India 48
BE - Belgio 35
CA - Canada 23
PL - Polonia 21
EU - Europa 14
JP - Giappone 11
RS - Serbia 10
NL - Olanda 8
RU - Federazione Russa 6
VN - Vietnam 6
AU - Australia 5
ID - Indonesia 5
CI - Costa d'Avorio 4
HK - Hong Kong 4
RO - Romania 4
ES - Italia 3
MY - Malesia 3
CH - Svizzera 2
IR - Iran 2
MX - Messico 2
NZ - Nuova Zelanda 2
TW - Taiwan 2
AL - Albania 1
AT - Austria 1
BR - Brasile 1
CL - Cile 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
PH - Filippine 1
PT - Portogallo 1
Totale 16.834
Salva come PNG Salva come JPEG
Città #
Chandler 1.476
Jacksonville 1.414
Fairfield 849
Dublin 747
Ashburn 645
Wilmington 551
Woodbridge 397
Boardman 369
Houston 363
Seattle 338
Des Moines 334
New York 332
Centro 325
Lawrence 298
Princeton 298
San Mateo 297
Cambridge 234
Ann Arbor 227
San Diego 114
Beijing 81
Turin 67
Pune 45
Los Angeles 43
Redmond 41
London 40
Washington 38
Marche 35
Brussels 32
Helsinki 32
Norwalk 28
Ancona 24
Jesi 22
Porto 20
Falls Church 19
Auburn Hills 18
Milan 16
Izmir 15
Kilburn 12
Rome 12
Castelfidardo 11
Ottawa 11
Belgrade 10
Iesi 10
Bologna 7
New Bedfont 7
Southwark 7
Tolentino 7
Brescia 6
Dong Ket 6
Hanover 6
Monte San Pietrangeli 6
Montréal 6
Ostra 6
San Giorgio A Cremano 6
Brisbane 5
Comunanza 5
Nürnberg 5
Prescot 5
San Benedetto Del Tronto 5
Sassoferrato 5
Squinzano 5
Torre Annunziata 5
Abidjan 4
Amandola 4
Chiaravalle 4
Montemarciano 4
Atella 3
Bucharest 3
Camerino 3
Chicago 3
Civitanova Marche 3
Corridonia 3
Falconara Marittima 3
Foggia 3
Frankfurt am Main 3
Kraków 3
Leawood 3
Medan 3
Nanjing 3
Osimo 3
Pagani 3
Pesaro 3
Petaling Jaya 3
Rosora 3
Rotella 3
San Benedetto del Tronto 3
Taranto 3
Wandsworth 3
Wuhan 3
Alameda 2
Ascoli Piceno 2
Bari 2
Borås 2
Casoria 2
Cerveteri 2
Chioggia 2
Fabriano 2
Fayetteville 2
Florence 2
Gambettola 2
Totale 10.507
Salva come PNG Salva come JPEG
Nome #
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 121
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 115
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 114
La terapia con immunoglobuline endovena nelle malattie autoimmuni 104
Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis 101
Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy 97
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 94
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 94
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 92
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 90
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 90
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 89
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis. 89
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 88
Piascledine modullates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes 86
Cognitive and cerebral hemodynamic impairment in scleroderma patients 86
Adalimumab modulates angiogenesis in psoriatic skin 85
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 85
Computed tomography assessment of evolution of interstitial lung disease in systemic sclerosis: Comparison of two scoring systems 84
Certolizumab pegol for the treatment of psoriasis 84
AIRE gene polymorphisms in Systemic Sclerosis associated with autoimmune thyroiditis 83
Subcutaneous IgG in the Myositis Spectrum Disorders 83
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 83
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 82
Cardiac involvement in polymyositis and dermatomyositis 82
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 82
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 82
A randomized controlled trial of Rituximab for the treatment of severe cryoglobulinemic vasculitis. 81
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 81
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 81
Identification of a novel human DRB1*13 allele by sequence-based DRB typing. 80
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 80
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients 80
Assessment of gastrointestinal involvement in scleroderma. 79
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 79
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 79
Successful treatment of a Caucasian case of multifocal Castleman¿s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report 78
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 78
c-myb but not B-myb upregulates a1(I) and a2(I) collagen genes in fibroblasts 77
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 77
Pathogenic autoantibodies in systemic sclerosis 76
c-myb proto-oncogene is expressed by quiescent fibroblasts and unlike B-myb gene does not correlate with proliferation 75
Scleroderma. 74
The risk of non-Hodgkin's lymphoma in coeliac disease: a case-control, multicentre study 74
Systemic sclerosis (scleroderma) and cancer risk: Systematic review and meta-analysis of observational studies 74
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 73
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 73
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 73
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. 73
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 73
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 73
Tocilizumab in COVID-19 interstitial pneumonia 73
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 72
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 72
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 72
Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis 72
c-MYB transactivates the alpha 2(I) collagen gene. 71
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 71
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 71
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 71
Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren's syndrome 71
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 71
Osservazione di una nuova mutazione puntiforme del gene p53 nel seminoma tipico del testicolo: descrizione di un caso 70
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis c virus infection? 70
Reduction of bcl-2 in T-cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erithematosus 70
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 70
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 70
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 69
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 69
BIOLOGIC THERAPY IN INFLAMMATORY AND IMMUNOMEDIATED ARTHRITIS: SAFETY PROFILE 69
Biologics in inflammatory and immunomediated arthritis 69
Mapping and predicting mortality from systemic sclerosis 69
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 69
Deflazacort moduletes the fibrynolitic pattern and reduces uPA-dependent chemoinvasion and proliferation in rheumatoid arthritis synoviocytes 68
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 68
TOSSE STIZZOSA: PRESENTAZIONE ATIPICA DI UNA VASCULITE DEI GRANDI VASI 68
Traiano: Educational (but not only) opportunity for Master Students 68
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact 68
Immunohistochemical localization of intracellular and extracellular associated TGFb in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon 67
Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies. 67
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 67
SpA and PsA basic and translational research OP0205 Gut Dysbiosis in Patients with HLA-B27+ Ankylosing Spondylitis is Associated with Ileitis, Down-Regulation of Tight Junction Proteins, Increased Serum Levels of LPS and Monocytes Anergy 67
Acute myocarditis associated with adenoviral infection in a patient with scleroderma 67
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 67
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 67
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 67
Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO registry 67
Recommendations for the management of biofilm: a consensus document. 67
Scleroderma fibroblasts constitutively express the long pentraxin PTX3. 66
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 66
Role of HLA class II in HCV-related disorders 65
Dynamics of hepatitis C virus viremia after perturbation by plasma exchange 65
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis 65
A novel HLA-Cw*6 allele Cw*160102, identified by cloning and sequencing. 65
Subcutaneous immunoglobulins in polymyositis and dermatomyositis: a novel application. 65
ALTERATIONS OF ROS PATHWAYS IN SCLERODERMA BEGIN AT STEM CELL LEVEL 65
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: Role of NADPH oxidase and ERK1/2 65
A painful diagnosis 65
Stimulatory autoantibodies against PDGF receptor in systemic sclerosis 64
Bone marrow endothelial progenitors are defective in systemic sclerosis 64
Totale 7.647
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.168
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201938 0 0 0 0 0 0 0 0 0 0 9 29
2019/20201.781 43 10 280 14 295 19 295 34 297 29 86 379
2020/20213.976 192 421 556 41 525 195 373 232 435 341 447 218
2021/20222.152 117 540 66 131 20 112 78 164 134 134 205 451
2022/20234.291 384 442 346 361 311 724 13 289 1.032 43 236 110
2023/20242.043 431 49 142 350 371 509 43 58 13 72 5 0
Totale 17.219